comparemela.com

Page 5 - Timothy Henry News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Genetesis Receives 2nd FDA Breakthrough Device Designation for Non-Invasive Diagnosis of Myocardial Ischemia Using CardioFlux MCG

Designation represents progress for patients with suspected Coronary Microvascular Dysfunction as the FDA recognizes disease’s debilitating impacts and the lack of effective non-invasive options for efficient diagnosis

Heart disease study shows hope for stem cell treatment

vimarsana © 2020. All Rights Reserved.